scholarly article | Q13442814 |
P50 | author | Søren Jacobsen | Q61093861 |
Anette Holck Draborg | Q87938319 | ||
Karen Duus | Q117518125 | ||
Gunnar Houen | Q54867196 | ||
Marie Westergaard | Q59685399 | ||
Janni Lisander Larsen | Q59705922 | ||
P2093 | author name string | Shila Mortensen | |
P2860 | cites work | Association of Epstein-Barr virus with systemic lupus erythematosus - effect modification by race, age, and cytotoxic T lymphocyte-associate antigen 4 genotype | Q23911107 |
Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors | Q24310589 | ||
Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood | Q24805330 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 | ||
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response | Q30442835 | ||
Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. | Q33223891 | ||
Understanding the epidemiology and progression of systemic lupus erythematosus | Q33621131 | ||
Exhausted cytotoxic control of Epstein-Barr virus in human lupus | Q34058156 | ||
An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus | Q34065673 | ||
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection | Q34082763 | ||
T cell activation via Leu-23 (CD69) | Q69212672 | ||
Epstein-Barr viral gene expression in B-lymphocytes | Q74788734 | ||
Infectious mononucleosis in middle age | Q78024122 | ||
Epstein-Barr virus: exploiting the immune system | Q34572150 | ||
Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study | Q34680728 | ||
Epstein-Barr virus in autoimmune diseases | Q34887020 | ||
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies | Q35456519 | ||
Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease | Q35787184 | ||
Cellular mechanisms governing cross-presentation of exogenous antigens | Q35821234 | ||
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages | Q36327656 | ||
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo | Q36350448 | ||
Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases | Q36464560 | ||
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. | Q36826932 | ||
Genetics of clinical expression in SLE. | Q37030643 | ||
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases | Q37146126 | ||
Systemic lupus erythematosus: clinical presentations. | Q37789958 | ||
Chronic Epstein-Barr virus infection | Q39509074 | ||
Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils | Q39539494 | ||
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication | Q40822849 | ||
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell | Q40843575 | ||
Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus | Q41104640 | ||
Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. | Q41191436 | ||
Infectious antibodies in systemic lupus erythematosus patients | Q42992383 | ||
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis. | Q43726837 | ||
Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan | Q44005208 | ||
An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus | Q44657983 | ||
Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. | Q45357292 | ||
Polymyositis/dermatomyositis and nasopharyngeal carcinoma: The Epstein–Barr virus connection? | Q45372464 | ||
Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. | Q45374201 | ||
Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease | Q45381481 | ||
High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. | Q45528509 | ||
Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. | Q45586250 | ||
Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus | Q45701078 | ||
Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus | Q45705505 | ||
Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection | Q45735795 | ||
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure | Q45737398 | ||
Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus | Q45797774 | ||
EBV and systemic lupus erythematosus: a new perspective. | Q51991919 | ||
The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. | Q52022569 | ||
Systemic lupus erythematosus. | Q53495545 | ||
Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. | Q55033100 | ||
P433 | issue | 1 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
Epstein–Barr virus | Q6900 | ||
lupus erythematosus | Q188297 | ||
P304 | page(s) | e000015 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | Lupus science & medicine | Q27725658 |
P1476 | title | Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients | |
P478 | volume | 1 |
Q40362391 | Chronic hepatitis C viral infection among SLE patients: the significance of coexistence |
Q40766488 | Coexistence of systemic lupus erythematosus, tuberous sclerosis and aggressive natural killer-cell leukaemia: coincidence or correlated? |
Q90212004 | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls |
Q35786726 | Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies. |
Q64235364 | Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay |
Q40473942 | Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus. |
Q54263338 | Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status. |
Q36784009 | Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients |
Q35948285 | Infection and Lupus: Which Causes Which? |
Q35591973 | Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies |
Q59349350 | Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity |
Q41960123 | Lupus Science and Medicine: the Editors present highlights for the bedside and for the bench in the inaugural issue |
Q46461196 | Strong viral associations with SLE among Filipinos |
Q51137468 | The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors. |
Q58554268 | The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis |
Search more.